PeterAMerkelMD

Rheumatology • Radnor, PA

Scleroderma & Related, Vasculitis

Professor, Medicine, Perelman School of Medicine

Join to view full profile

Dr. Merkel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Merkel's full profile

Already have an account?

Office
250 King of Prussia Rd
Radnor, PA 19087
Phone+1 610-902-5700

Fax+1 617-638-5226

Education & Training

Harvard School of Public HealthM.P.H., 1995
Massachusetts General HospitalFellowship, Rheumatology, 1992 - 1994
University of Pennsylvania Health SystemResidency, Internal Medicine, 1988 - 1991
Yale School of MedicineClass of 1988
Wesleyan UniversityB.A., 1983

Certifications & Licensure

FL State Medical License 2022 - Present
NJ State Medical License 2018 - 2025
PA State Medical License 1990 - 2024
MA State Medical License 1992 - 2019
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Philadelphia Magazine Castle Connolly, 2013-2014
America's Top Doctors Castle Connolly, 2006-2011, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Named a "Top Doc" Philadelphia Magazine, 2012-2013
Fellow American College of Physicians, 2012
Fellow College of Physicians of Philadelphia Society, 2011
Boston Magazine Castle Connolly, 2008-2010
Named among the "Best Doctors" in America 2006
Named one of "America's Top Doctors" Castle Connolly Medical Ltd, 2005
Named among the "Best of Boston" Physicians Boston Magazine, 2002-2003, 2007
Named among the "Best of Boston" Physicians for Women Boston Magazine, 2001
Lange Book Award for Academic Achievement Yale University School of Medicine, 1988
Louis G. Welt Prize for Outstanding Thesis Yale University School of Medicine, 1988
Award for the outstanding paper in diabetes research, National Student Research Forum American Diabetes Association, 1987
Awarded Scholarship in Clinical Nutrition American Medical Association, 1987
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow American College of Rheumatology
Join now to see all

Clinical Trials

Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis Start of enrollment: 2006 Apr 01
Recruiting
Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis Start of enrollment: 2006 Apr 01
Completed
Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa Start of enrollment: 2006 Apr 01
Completed
Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis Start of enrollment: 2006 Apr 01
Completed
Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis Start of enrollment: 2006 Apr 01
Completed
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis Start of enrollment: 2008 Feb 01
Completed
Phase 1, Phase 2
Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis Start of enrollment: 2008 Dec 01
Completed
Phase 2
Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis Start of enrollment: 2008 Aug 01
Completed
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis Start of enrollment: 2010 May 01
Completed
Phase 3
American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis Start of enrollment: 2011 Jan 01
Unknown status
One-Time DNA Study for Vasculitis Start of enrollment: 2010 Oct 01
Recruiting
Rituximab Vasculitis Maintenance Study Start of enrollment: 2013 Apr 01
Completed
Phase 3
The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach Start of enrollment: 2014 Feb 17
Active, not recruiting
Phase 3
The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach Start of enrollment: 2014 Feb 01
Active, not recruiting
Phase 3
Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) Start of enrollment: 2015 Apr 25
Active, not recruiting
Phase 3
Vasculitis Illness Perception (VIP) Study Start of enrollment: 2011 Oct 01
Completed
Educational Needs of Patients With Systemic Vasculitis Start of enrollment: 2012 Mar 01
Completed
VCRC Patient Contact Registry Patient-Reported Data Validation Study Start of enrollment: 2014 May 01
Completed
VCRC Tissue Repository Start of enrollment: 2016 Nov 01
Recruiting
VCRC Longitudinal Protocol for Aortitis Start of enrollment: 2017 Dec 04
Completed
Journey of Patients With Vasculitis From First Symptom to Diagnosis Start of enrollment: 2018 Jan 11
Completed
Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis Start of enrollment: 2019 Feb 04
Recruiting
Phase 2
Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA Start of enrollment: 2018 Oct 15
Terminated
Phase 2
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis (PEXIVAS) - Glucocorticoids
Abatacept for the Treatment of Giant Cell Arteritis Start of enrollment: 2021 Mar 15
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

510 citations
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
Michael E. Wechsler, Praveen Akuthota, David Jayne, Paneez Khoury, Amy D. Klion
The New England Journal of Medicine. 2017-05-17
276 citations
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.
Matthieu Groh, Christian Pagnoux, Chiara Baldini, Elisabeth H. Bel, Paolo Bottero
European Journal of Internal Medicine. 2015-09-01
189 citations
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis.
Peter C Grayson, Cristina Ponte, Ravi Suppiah, Joanna C Robson, Anthea Craven
Annals of the Rheumatic Diseases. 2022-03-01

Journal Articles

Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory Features
Zachary M Dong, Michael E Wechsler, Praveen Akuthota, Peter A Merkel, Ulrich Specks, Benjamin Raby, Frederic Clayton, The American Journal of Pathology
Role of Macrophage Migration Inhibitory Factor in Granulomatosis with Polyangiitis
Peter A Merkel, Curry L Koening, Antoine G Sreih, Arthritis & Rheumatology
Mapping of the OMERACT core set for ANCA-associated vasculitis to the international classification of function, disability and health
Milman N, Boonen A, Merkel PA, Tugwell P, Arthritis Care Res, 1/21/2014
Peripheral CD5+ B-cells in ANCA-associated vasculitis
Unizony S, Lim N, Phippard DJ, Carey VJ, Miloslavsky EM, Tchao NK, Ikle D, Asare AL, Merkel PA, Monach PA, Seo P, St Clair EW, Langford CA, Spiera R, Hoffman GS, Kalle..., Arthritis Rheumatol, 1/20/2014
Current Status of Outcome Measure Development in Vasculitis
Merkel PA, Aydin SZ, Boers M, Cornell C, Direskeneli H, Gebhart D, Hatemi G, Luqmani R, Matteson EL, Milman N, Robson J, Seo P, Tomasson G, Journal of Rheumatology, 1/15/2014
Alcohol-induced vasculitis: Case report and commentary
Abuabara K, Samimi S, Chu EY, Bluebond ND, James WD, Merkel PA, Journal of the American Academy of Dermatology, 1/1/2014
Brief report: the value of a patient global assessment of disease activity in granulomatosis with polyangiitis (Wegener's)
Tomasson G, Davis JC, Hoffman GS, McCune WJ, Specks U, Spiera R, St Clair EW, Stone JH, Merkel PA, Arthritis & Rheumatology, 1/1/2014
Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosis
Wiese AB, Berrocal VJ, Furst DE, Seibold JR, Merkel PA, Mayes MD, Khanna D, Arthritis Care Res, 1/1/2014
Outcome Measures Used in Clinical Trials for Behcet Syndrome: A Systematic Review
Hatemi G, Merkel PA, Hamuryudan V, Boers M, Direskeneli H, Aydin SZ, Yazici H, Journal of Rheumatology, 1/1/2014
Patient-powered research networks: building capacity for conducting patient-centered clinical outcomes research
PCORnet PPRN Consortium, Daugherty SE, Wahba S, Fleurence R. Collaborators: Avillach P, Buelow J, Colletti R, Eichler F, Ginsberg S, Dewitt EM, McBurney R, Merkel PA, ..., J Am Med Inform Assoc, 1/1/2014
Risk of Cardiovascular Disease Early and Late After a Diagnosis of Giant Cell Arteritis
Tomasson G, Peloquin C, Mohammad A, Love TJ, Zhang Y, Choi HK, Merkel PA, Annals of Internal Medicine, 1/1/2014
Updating the OMERACT Filter: Core Areas as a Basis for Defining Core Outcome Sets
Kirwan JR, Boers M, Hewlett S, Beaton D, Bingham CO 3rd, Choy E, Conaghan PG, D'Agostino MA, Dougados M, Furst DE, Guillemin F, Gossec L, van der Heijde DM, Kloppenbur..., J Rheumatol, 1/1/2014
Variability of the Impact of Adverse Events on Physicians' Decision Making
Cozmuta R, Wahl ER, Merkel PA, Fraenkel L, BMC Medical Informatics and Decision Making, 1/1/2014
Incidence and Mortality Rates of Biopsy-Proven Giant Cell Arteritis in Southern Sweden
Mohammad AJ, Nilsson J, Jacobsson L, Merkel PA, Turesson C, Annals of Rheumatic Diseases, 1/17/2013
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langf..., Arthritis & Rheumatism, 1/1/2013
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, ..., Ann Rheum Dis, 1/1/2013
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, ..., Arthritis Rheum, 1/1/2013
ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS)
Craven A, Robson J, Ponte C, Grayson PC, Suppiah R, Judge A, Watts R, Merkel PA, Luqmani RA, Clin Exp Nephrol, 1/1/2013
An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)
Langford CA, Monach PA, Specks U, Seo P, Cuthbertson D, McAlear CA, Ytterberg SR, Hoffman GS, Krischer JP, Merkel PA, Ann Rheum Dis, 1/1/2013
Granulomatosis with polyangiitis (Wegener’s) is associated with HLA-DPB1*04 and SEMA6A gene variants: Evidence from genome-wide analysis
Xie G, Roshandel D, Sherva R, Monach PA, Lu Y, Kung T, Carrington K, Zhang SS, Pulit SL, Ripke S, Carette S, Dellaripa PF, Edberg JC, Hoffman GS, Khalidi N, Langford ..., Arthritis & Rheumatism, 1/1/2013
Identification of Multiple Genetic Susceptibility Loci in Takayasu Arteritis
Am J Hum Genet, 1/1/2013
Illness perceptions and fatigue in systemic vasculitis
Grayson PC, Amudala NA, McAlear CA, Leduc RL, Shereff D, Richesson R, Fraenkel L, Merkel PA, Arthritis Care Res, 1/1/2013
Maintenance of Rituximab-induced Remissions in ANCA-Associated Vasculitis
Specks S, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CGM, St. Clair EW, Fessler B, Ding L, Webber L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle ..., New England Journal of Medicine, 1/1/2013
New Features of Disease after Diagnosis in Six Forms of Systemic Vasculitis
Grayson PC, Cuthbertson DC, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, Monach PA, Seo P, Specks U, Ytterberg SR, Merkel PA for..., Journal of Rheumatology, 1/1/2013
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled ...
Walsh M, Merkel PA, Peh CA, Szpirt W, Guillevin L, Pusey CD, Dezoysa J, Ives N, Clark WF, Quillen K, Winters JL, Wheatley K, Jayne D; PEXIVAS Investigators, Trials, 1/1/2013
Join now to see all

Books/Book Chapters

Atlas of Vascular Medicine
Chapter: Vasculitis
Mahr AD, Merkel PAEditors: Creager M.Elsevier, Philadelphia, PAEdition 3rd,2007
Cecil Essentials of Medicine
Chapter: Approach to the Patient with Rheumatic Disease.
Merkel PA, Simms RWEditors: Andreoli TE, Carpenter, CCJ, Griggs, RC, Loscalzo, J.W.B. Saunders Company, Philadelphia, PAEdition 7th,2007
Cecil Essentials of Medicine
Chapter: Crystal Arthropathies.
Simms RW, Merkel PAEditors: Andreoli TE, Carpenter, CCJ, Griggs, RC, Loscalzo, J.W.B. Saunders Company, Philadelphia, PAEdition 7th,2007
Cecil Essentials of Medicine
Chapter: Rheumatoid Arthritis.
Merkel PA, Simms RWEditors: Andreoli TE, Carpenter, CCJ, Griggs, RC, Loscalzo, J.W.B. Saunders Company, Philadelphia, PAEdition 7th,2007
Cecil Essentials of Medicine
Chapter: Systemic Sclerosis (Scleroerma).
Simms RW, Merkel PAEditors: Andreoli TE, Carpenter, CCJ, Griggs, RC, Loscalzo, J.W.B. Saunders Company, Philadelphia, PAEdition 7th,2007
Vascular Medicine.
Chapter: Giant Cell Arteritis.
Cid M, Merkel PAEditors: Creager M, Loscalzo J.Elsevier, Philadelphia, PAEdition 3rd,2006
Vascular Medicine.
Chapter: Overview of Vasculitis.
Merkel PAEditors: Creager M, Loscalzo J.Elsevier, Philadelphia, PAEdition 3rd,2006
Peripheral Arterial Disease: Diagnosis and Treatment.
Chapter: Large Vessel Vasculitis.
Page 319 - 345Kissin E, Merkel PAEditors: Coffman JD, Eberhardt RT.The Humana Press, Totowa, NJ2003
Primer in Rheumatic Disease.
Chapter: Rheumatologic Manifestations of Endocrine Diseases.
Page 435 - 439Merkel PAEditors: Klippel, JH.Arthritis Foundation, Atlanta, GAEdition 12th,2002
Inflammatory Diseases of Blood Vessels
Chapter: Drug-Induced Vasculitis.: Drug-Induced Vasculitis.
Page 727 - 746Merkel PAEditors: Hoffman, GS and Weyand, CM.Marcel Dekker, Inc., New York, NY2001
Cecil Essentials of Medicine
Chapter: Antiphospholipid Antibody Syndrome.
Merkel PAEditors: Andreoli TE, Carpenter, CCJ, Griggs, RC, Loscalzo, J.W.B. Saunders Company, Philadelphia, PAEdition 5th,2001
Cecil Essentials of Medicine
Chapter: Sjogren's Syndrome.
Merkel PAEditors: Andreoli TE, Carpenter, CCJ, Griggs, RC, Loscalzo, J.W.B. Saunders Company, Philadelphia, PAEdition 5th,2001
Cecil Essentials of Medicine
Chapter: Spondyloarthropathies.
Merkel PAEditors: Andreoli TE, Carpenter, CCJ, Griggs, RC, Loscalzo, J.W.B. Saunders Company, Philadelphia, PAEdition 5th,2001
Cecil Essentials of Medicine
Chapter: Systemic Lupus Erythematosus.
Merkel PAEditors: Andreoli TE, Carpenter, CCJ, Griggs, RC, Loscalzo, J.W.B. Saunders Company, Philadelphia, PAEdition 5th,2001
Cecil Essentials of Medicine
Chapter: Vasculitides.
Merkel PAEditors: Andreoli TE, Carpenter, CCJ, Griggs, RC, Loscalzo, J.W.B. Saunders Company, Philadelphia, PAEdition 5th,2001
Join now to see all

Lectures

Past, Present, and Future of Clinical Trials in Vasculitis. Visiting Professor
Fudan Medical University, Shanghai, China - 1/1/2014
ANCA-Associated Vasculitis. Visiting Professor
University of Pittsburgh, Pittsburgh, PA - 1/1/2014
ANCA-Associated Vasculitis: Evaluation and Management
1/29/2013
Building your Research Portfolio.
San Diego, CA - 1/27/2013
Dos and Dont’s of Grant Writing
Dallas, TX - 1/22/2013
Past, Present, and Future of Clinical Trials in Vasculitis
University of Michigan - 1/21/2013
The Future of International Trials in Vasculitis
Paris, France - 1/17/2013
The CRISS protocol (Combined Response Index for Systemic Sclerosis).
Boston, MA - 1/7/2013
Advances in the Evaluation and Management of Vasculitis.
1/4/2013
Update on the Vasculitis Clinical Research Consortium.
Toronto Western Hospital, Toronto, Ontario, Canada - 1/1/2013
Clinical Investigation of Vasculitis: Activities of the Vasculitis Clinical Research Consortium
Tokyo, Japan - 1/28/2012
Current Clinical Controversies in Vasculitis
Nova Scotia, Canada - 1/9/2012
ANCA-Associated Vasculitis: An Update for Internists
Henry Ford Hospital - 1/7/2012
Biomarkers in Vasculitis
1/1/2012
ANCA-Associated Vasculitis: Classification, Diagnosis, and Monitoring
Los Angeles, CA - 1/30/2011
ANCA-Associated Vasculitis: Treatment with Immunosuppressive, Biologic, and Experimental Agents
Los Angeles, CA - 1/30/2011
Current Controversies in Clinical Vasculitis
1/29/2011
Mimics of Vasculitis. Invited Speaker
Waltham, MA - 1/19/2011
Defining Disease Activity and Damage in Patients with Small Vessel Vacuities
Cleveland, OH - 1/14/2011
Clinical Research in Vasculitis
University of Pennsylvania, Philadelphia, PA - 1/10/2011
Takayasu’s Arteritis
Chicago, IL - 1/8/2011
Recent and Future Clinical Trials in Vasculitis
Beth Israel Deaconess Medical Center, Boston, MA - 1/7/2011
Clinical Features and Management of Rheumatoid Arthritis and Sjögren's Syndrome
Boston University School of Medicine - 1/1/2011
How to Write a Research Proposal
Boston University School of Medicine - 1/1/2011
Utilizing the GCRC for Research Training
Boston University School of Medicine - 1/1/2011
Join now to see all

Other

Takayasu's Arteritis. Patient education material from The American College of Rhematology
Monach PA, Merkel PA
www.rheumatology.org/public/factsheets
1/1/2012
Vasculitis. Patient education material from The American College of Rhematology
Monach PA, Merkel PA
www.rheumatology.org/public/factsheets
1/1/2012
Patient education material from The American College of Rhematology.
Korn JH, Merkel PA, Scleroderma
www.rheumatology.org/public/factsheets
1/1/2009
Arthritis episode of "Doctors On Call" television program. Expert panelist.
Merkel P, WABU-TV
Boston, MA - 1/1/1998
Clinical manifestations and diagnosis of polyarteritis nodosa
Merkel PA
http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-polyarteritis-nodosa
UpToDate, Wolters Kluwer Health - 2012-11-28
Join now to see all

Authored Content

Effect of Avacopan, a Selective C5a Receptor Inhibitor, on Kidney Function in Patients with ANCA-Associated VasculitisOctober 2021
Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
Join now to see all

Press Mentions

Researchers Aim to Use AI to Predict Rare DiseasesSeptember 21st, 2022
Kyverna Therapeutics Names Georg Schett, M.D., and Peter a. Merkel, M.D., MPH, to Scientific Advisory BoardAugust 23rd, 2022
Two Steps Forward, One Step Back: Hunting for a Game-Changer in SclerodermaMarch 22nd, 2022
Join now to see all

Grant Support

Conference On Clinical Research For RARE DiseasesNational Institute Of Neurological Disorders And Stroke2010–2011
Vasculitis Clinical Research ConsortiumNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2011
Plasma Exchange And Glucocorticoids For Treatment Of Anca-Associated VasculitisFood And Drug Administration2009–2011
Identification And Validation Of Biomarkers For VasculitisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2010
Interpaly Of Thrombosis And Inflammation In VasculitisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2010
Vasculitis Clinical Research Network (Vcrn): RARE DiseaseNational Center For Research Resources2004–2008
Vasculitis Clinical Research Network (VCRN)National Center For Research Resources2003–2008
Vcrc Longitudinal Study For Wegener'S Granulomatosis And Microscopic PolyangitisNational Center For Research Resources2007
Vcrc Longitudinal Study For Takayasu'S ArteritisNational Center For Research Resources2007
Vcrc Longitudinal Study For Polyarteritis NodosaNational Center For Research Resources2007
Vcrc Longitudinal Study For Churg-Strauss SyndromeNational Center For Research Resources2007
IL-1 TRAP Administered Sub-Cutaneously In Subjects W Relapsing PolymalgiaNational Center For Research Resources2007
Clinical Research For RARE Diseases: Opportunities, Challenges, And SolutionsNational Center For Research Resources2007
Rituximab Therapy For Remission And Tolerance In ANCA Associated VasculitisNational Center For Research Resources2006–2007
Vasculitis Outcome Measures: Development And ValidationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006
Study Of Enbrel In The Treatment Of Wegener'S GranulomatosisNational Center For Research Resources2005
Development And Validation Of Outcome Measures For Systemic SclerosisNational Center For Research Resources2005
Genetic Polymorphisms In Wegener'S GranulomatosisNational Center For Research Resources2004–2005
Studies In Scleroderma And Cystic Fibrosis OsteoporosisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001–2005
Study Of Enbrel In Treatment Of Wegener'S GranulomatosisNational Center For Research Resources2004
Outcome Measures For Systemic SclerosisNational Center For Research Resources2004
Clinical And Biochemical Markers Of Osteoporosis In PTS With Cystic FibrosisNational Center For Research Resources2004
Prevalence And Clinical Characteristics Of Cystic Fibrosis ArthropathyNational Center For Research Resources1997–2002
Clinical And Biochemical Markers Of Osteoporosis In Cystic FibrosisNational Center For Research Resources1996–2002
Study Administering Mycophenolate Mofetil For Active Rheumatoid ArthritisNational Center For Research Resources1999–2001
Administering (Mmf RS 61443) PO (1g Bid) In PTS W/ Active Rheumatoid ArthritisNational Center For Research Resources1999–2000
Efficacy/Safety Of Mycophenolate Mofetil Immunotherapy In Rheumatoid ArthritisNational Center For Research Resources1998–2000
Mmf-Rs 61443 In Patients With Active Rheumatoid ArthritisNational Center For Research Resources1999
Recombinant Human Relaxin In PTS W/ Systemic Sclerosis With Diffuse SclerodermaNational Center For Research Resources1997–1999
Oral Iloprost &Placebo In Raynaud'S Phenomenon Secondary To Systemic SclerosisNational Center For Research Resources1997
Cystic Fibrosis Arthropathy StudyNational Center For Research Resources1996